Folate/homocysteine phenotypes and MTHFR 677C>T genotypes are associated with serum levels of monocyte chemoattractant protein-1

Clinical Immunology

Volumn 133, Issue 1, 2009, Pages 132-137

  Hammons, Andrea L ^a   Summers, Carolyn M ^a   Woodside, Jayne V ^b   McNulty, Helene ^c   Strain, J J ^c   Young, Ian S ^b   Murray, Liam ^b   Boreham, Colin A ^d   Scott, John M ^e   Mitchell, Laura E ^f   Whitehead, Alexander S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c UNIVERSITY OF ULSTER   (United Kingdom)

^d UNIVERSITY COLLEGE DUBLIN   (Ireland)

^e TRINITY COLLEGE DUBLIN   (Ireland)

^f TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

Autoimmune; Folate; Homocysteine; MCP 1

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLIC ACID; HOMOCYSTEINE; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; ARTICLE; COMPREHENSION; CONTROLLED STUDY; CORRELATIONAL STUDY; ERYTHROCYTE; FEMALE; FOLIC ACID BLOOD LEVEL; GENOTYPE; HETEROZYGOTE; HUMAN; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; SMOKING; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; CHEMOKINE CCL2; FEMALE; FOLIC ACID; GENOTYPE; HETEROZYGOTE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); SEX FACTORS; YOUNG ADULT;

EID: 69949174316     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2009.06.008     Document Type: Article

References (28)

1. Refsum H., Ueland P.M., Nygard O., and Vollset S.E. Homocysteine and cardiovascular disease. Annu. Rev. Med. 49 (1998) 31-62
2. van der Put N.M., Thomas C.M., Eskes T.K., Trijbels F.J., Steegers-Theunissen R.P., Mariman E.C., De Graaf-Hess A., Smeitink J.A., and Blom H.J. Altered folate and vitamin B12 metabolism in families with spina bifida offspring. QJM 90 (1997) 505-510
3. Ueland P.M., Hustad S., Schneede J., Refsum H., and Vollset S.E. Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol. Sci. 22 (2001) 195-201
4. Wallberg-Jonsson S., Cvetkovic J.T., Sundqvist K.G., Lefvert A.K., and Rantapaa-Dahlqvist S. Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis. J. Rheumatol. 29 (2002) 875-882
5. Chiang E.P., Bagley P.J., Selhub J., Nadeau M., and Roubenoff R. Abnormal vitamin B(6) status is associated with severity of symptoms in patients with rheumatoid arthritis. Am. J. Med. 114 (2003) 283-287
6. Von Feldt J.M., Scalzi L.V., Cucchiara A.J., Morthala S., Kealey C., Flagg S.D., Genin A., Van Dyke A.L., Nackos E., Chander A., Gehrie E., Cron R.Q., and Whitehead A.S. Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus. Arthritis Rheum. 54 (2006) 2220-2227
7. Jacques P.F., Bostom A.G., Williams R.R., Ellison R.C., Eckfeldt J.H., Rosenberg I.H., Selhub J., and Rozen R. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93 (1996) 7-9
8. Harmon D.L., Woodside J.V., Yarnell J.W., McMaster D., Young I.S., McCrum E.E., Gey K.F., Whitehead A.S., and Evans A.E. The common 'thermolabile' variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia. QJM 89 (1996) 571-577
9. Graves D.T., and Jiang Y. Chemokines, a family of chemotactic cytokines. Crit. Rev. Oral Biol. Med. 6 (1995) 109-118
10. Noris M., Bernasconi S., Casiraghi F., Sozzani S., Gotti E., Remuzzi G., and Mantovani A. Monocyte chemoattractant protein-1 is excreted in excessive amounts in the urine of patients with lupus nephritis. Lab. Invest. 73 (1995) 804-809
11. Koch A.E., Kunkel S.L., Harlow L.A., Johnson B., Evanoff H.L., Haines G.K., Burdick M.D., Pope R.M., and Strieter R.M. Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. J. Clin. Invest. 90 (1992) 772-779
12. Poddar R., Sivasubramanian N., DiBello P.M., Robinson K., and Jacobsen D.W. Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease. Circulation 103 (2001) 2717-2723
13. Brown K.S., Huang Y., Lu Z.Y., Jian W., Blair I.A., and Whitehead A.S. Mild folate deficiency induces a proatherosclerotic phenotype in endothelial cells. Atherosclerosis 189 (2006) 133-141
14. Brown K.S., Nackos E., Morthala S., Jensen L.E., Whitehead A.S., and Von Feldt J.M. Monocyte chemoattractant protein-1: plasma concentrations and A(-2518)G promoter polymorphism of its gene in systemic lupus erythematosus. J. Rheumatol. 34 (2007) 740-746
15. Lu Z.Y., Morales M., Khartulyari S., Mei M., Murphy K.M., Stanislawska-Sachadyn A., Summers C.M., Huang Y., Von Feldt J.M., Blair I.A., Mitchell L.E., and Whitehead A.S. Genetic and biochemical determinants of serum concentrations of monocyte chemoattractant protein-1, a potential neural tube defect risk factor. Birth Defects Res., A Clin. Mol. Teratol. 82 (2008) 736-741
16. Bielinski S.J., Pankow J.S., Miller M.B., Hopkins P.N., Eckfeldt J.H., Hixson J., Liu Y., Register T., Myers R.H., and Arnett D.K. Circulating MCP-1 levels shows linkage to chemokine receptor gene cluster on chromosome 3: the NHLBI family heart study follow-up examination. Genes Immun. 8 (2007) 684-690
17. McDermott D.H., Yang Q., Kathiresan S., Cupples L.A., Massaro J.M., Keaney Jr. J.F., Larson M.G., Vasan R.S., Hirschhorn J.N., O'Donnell C.J., Murphy P.M., and Benjamin E.J. CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study. Circulation 112 (2005) 1113-1120
18. Stanislawska-Sachadyn A., Woodside J.V., Brown K.S., Young I.S., Murray L., McNulty H., Strain J.J., Boreham C.A., Scott J.M., Whitehead A.S., and Mitchell L.E. Evidence for sex differences in the determinants of homocysteine concentrations. Mol. Genet. Metab. 93 (2008) 355-362
19. Boreham C., Twisk J., van Mechelen W., Savage M., Strain J., and Cran G. Relationships between the development of biological risk factors for coronary heart disease and lifestyle parameters during adolescence: the Northern Ireland Young Hearts Project. Public Health 113 (1999) 7-12
20. Ubbink J.B., Hayward Vermaak W.J., and Bissbort S. Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. J. Chromatogr. 565 (1991) 441-446
21. Kluijtmans L.A., Young I.S., Boreham C.A., Murray L., McMaster D., McNulty H., Strain J.J., McPartlin J., Scott J.M., and Whitehead A.S. Genetic and nutritional factors contributing to hyperhomocysteinemia in young adults. Blood 101 (2003) 2483-2488
22. Molloy A.M., and Scott J.M. Microbiological assay for serum, plasma, and red cell folate using cryopreserved, microtiter plate method. Methods. Enzymol. 281 (1997) 43-53
23. Lu Z.Y., Jensen L.E., Huang Y., Kealey C., Blair I.A., and Whitehead A.S. The up-regulation of monocyte chemoattractant protein-1 (MCP-1) in Ea.hy 926 endothelial cells under long-term low folate stress is mediated by the p38 MAPK pathway. Atherosclerosis 205 (2009) 48-54
24. Rovin B.H., Lu L., and Saxena R. A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem. Biophys. Res. Commun. 259 (1999) 344-348
25. Fenoglio C., Galimberti D., Lovati C., Guidi I., Gatti A., Fogliarino S., Tiriticco M., Mariani C., Forloni G., Pettenati C., Baron P., Conti G., Bresolin N., and Scarpini E. MCP-1 in Alzheimer's disease patients: A-2518G polymorphism and serum levels. Neurobiol. Aging 25 (2004) 1169-1173
26. Wang G., Dai J., Mao J., Zeng X., Yang X., and Wang X. Folic acid reverses hyper-responsiveness of LPS-induced chemokine secretion from monocytes in patients with hyperhomocysteinemia. Atherosclerosis 179 (2005) 395-402
27. Caballero-Campo P., Dominguez F., Coloma J., Meseguer M., Remohi J., Pellicer A., and Simon C. Hormonal and embryonic regulation of chemokines IL-8, MCP-1 and RANTES in the human endometrium during the window of implantation. Mol. Hum. Reprod. 8 (2002) 375-384
28. Jensen L.E., Etheredge A.J., Brown K.S., Mitchell L.E., and Whitehead A.S. Maternal genotype for the monocyte chemoattractant protein 1 A(-2518)G promoter polymorphism is associated with the risk of spina bifida in offspring. Am. J. Med. Genet., A 140 (2006) 1114-1118